Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Affymetrix DMET platform and pharmacogenetics in drug development.

Current opinion in molecular therapeutics - 1 Jun 2009

Deeken John

Abstract excerpt

The promise of medical care in the 21st century is that of 'personalized medicine'. Using the tool of pharmacogenetics, physicians may soon be able to choose drugs and dosages tailored toward specific patients based on their genetic profile and the genetic basis of their disease. To reach this goal, pharmacogenetics needs to be better incorporated into clinical research and drug development. Historically,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Drug Discovery
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inactivation, Metabolic

Share to Oligonucleotide Array Sequence Analysis

Share to Pharmacogenetics

Source

Identifiers

PMID: 19479659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Affymetrix DMET platform and pharmacogenetics in drug development.PMID 19479659Read ↗

Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies.Semantic proximity Read ↗

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.Semantic proximity Read ↗

Clinical Pharmacology and Pharmacogenetics in a Genomics Era: The DMET PlatformSemantic proximity Read ↗

The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.Semantic proximity Read ↗

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System.Semantic proximity Read ↗

Candidate gene approach for pharmacogenetic studies.Semantic proximity Read ↗

Development of a broad-based ADME panel for use in pharmacogenomic studies.Semantic proximity Read ↗

DMET-analyzer: automatic analysis of Affymetrix DMET data.Semantic proximity Read ↗

Current pharmacogenomic approaches to clinical drug development.Semantic proximity Read ↗

Pharmacogenetics and personalized treatment of type 2 diabetesSemantic proximity Read ↗

Pharmacogenomics of membrane transporters: past, present and future.Semantic proximity Read ↗

Technologies for detecting genetic polymorphisms in pharmacogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.